Organogenesis Holdings, Inc. (ORGO)
0.77
-0.02
(-2.43%)
USD |
NASDAQ |
Nov 20, 09:30
Organogenesis Holdings Cash from Investing (Quarterly) : 2.146M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.146M |
| June 30, 2026 | -1.10M |
| March 31, 2026 | -3.146M |
| December 31, 2025 | -4.652M |
| September 30, 2025 | -2.235M |
| June 30, 2025 | -3.638M |
| March 31, 2025 | -3.626M |
| December 31, 2024 | -3.361M |
| September 30, 2024 | -2.569M |
| June 30, 2024 | -1.88M |
| March 31, 2024 | -2.222M |
| December 31, 2023 | -3.324M |
| September 30, 2023 | -5.979M |
| June 30, 2023 | -7.499M |
| March 31, 2023 | -7.562M |
| December 31, 2022 | -10.66M |
| September 30, 2022 | -10.40M |
| June 30, 2022 | -6.168M |
| March 31, 2022 | -6.672M |
| December 31, 2021 | -5.227M |
| Date | Value |
|---|---|
| September 30, 2021 | -16.70M |
| June 30, 2021 | -4.512M |
| March 31, 2021 | -4.778M |
| December 31, 2020 | -5.418M |
| September 30, 2020 | -11.96M |
| June 30, 2020 | -1.875M |
| March 31, 2020 | -4.243M |
| December 31, 2019 | -3.458M |
| September 30, 2019 | -1.275M |
| June 30, 2019 | -1.184M |
| March 31, 2019 | -0.317M |
| December 31, 2018 | -1.856M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| cbdMD, Inc. | -0.0181M |
| Guardian Pharmacy Services, Inc. | -10.38M |
| Lineage Cell Therapeutics, Inc. | -5.147M |
| Tenax Therapeutics, Inc. | 0.00 |
| Heron Therapeutics, Inc. | 10.09M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.59M |
| Cash from Financing (Quarterly) | -3.459M |
| Free Cash Flow | -0.064M |
| Free Cash Flow Per Share (Quarterly) | -0.1555 |
| Free Cash Flow to Equity (Quarterly) | -17.63M |
| Free Cash Flow to Firm (Quarterly) | -20.00M |
| Free Cash Flow Yield | -0.06% |